Spectrum of Malignant Lymphoma in Queen Elizabeth Hospital, Sabah

Medical Journal of Malaysia

Volumn 58, Issue 4, 2003, Pages 546-555

  Peh, S C ^a   Shaminie, J ^a   Jayasurya, P ^b   Hiew, J ^b  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b Queen Elizabeth Hospital   (Malaysia)

Author keywords

EBV; Lymphoma; Malaysia; Sabah

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; B CELL LYMPHOMA; BURKITT LYMPHOMA; CANCER CLASSIFICATION; CANCER INCIDENCE; CELL TYPE; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; FOLLICULAR LYMPHOMA; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LARGE CELL LYMPHOMA; LYMPHOMA; MAJOR CLINICAL STUDY; MALAYSIA; MALE; NONHODGKIN LYMPHOMA; PHENOTYPE; PREVALENCE; SCHOOL CHILD; SEX DIFFERENCE; T CELL LYMPHOMA; TISSUE SECTION; TUMOR BIOPSY; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPHOMA; MALAYSIA; MALE; MIDDLE AGED;

EID: 1542314412     PISSN: 03005283     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Hartge P, Devesa SS, and Fraumeni, JF Jr. Hodgkin's and Non-Hodgkin's lymphomas. Cancer Surv 1994; 19/20: 423-53.
2. Chan WC. The Reed-Sternberg Cell in Classical Hodgkin's Disease. Hematol Oncol 2001; 19: 1-17.
3. Stein H, and Hummel M. Cellular Origin and Clonality of Classic Hodgkin's Lymphoma: Immunophenotypic and Molecular Studies. Semin Hematol 1999; 36: 233-41.
4. Jaffe ES, Harris NL, Diebold J, and Muller-Hermelink HK. World Health Organization Classification of lymphomas: A work in progress. Ann Oncol 1998; 9: S25-30.
5. Pisani P, Bray F, and Parkin DM. Estimates of the Worldwide Prevalence of Cancer For 25 Sites in the Adult Population. Int. J. Cancer 2002; 97: 72-81.
6. Devesa SS, and Fear T. Non-Hodgkin's lymphoma time trends: United States and international data. Cancer Res (Suppl) 1992; 52: 5432s-40s.
7. Toren A, Ben-Bassat, and Rechavi G. Infectious agents and environmental factors in lymphoid malignancies. Blood Reviews 1996; 10: 89-94.
8. Sng I, Levin A, Jaffe ES, Ng HW et al. T-cell lymphoma in Singapore: pathology, clinical findings and association with HTLV-1 antibodies. Histopathology 1992; 22: 101-13.
9. Su IJ, Shih LY, Kadin ME, Dun P, and Hsu SM. Pathologic and immunologic characterization of malignant lymphoma in Taiwan. With special reference to retrovirus-related adult T-cell lymphoma/leukaemia. Am J Clin Pathol 1985; 84: 715-23.
10. Ho FCS, Loke SL, Hui PK, and Todd D. Immunohistological subtypes of non-Hodgkin's lymphoma in Hong Kong Chinese. Pathology 1986; 18: 426-30.
11. Blatter WA, Kalyanaraman VS, Robert-Gurroff M et al. The human type C retrovirus HTLV in blacks from the Caribbean region and its relationship to adult T-cell leukaemia/lymphoma. Int J Cancer 1982; 30: 257-64.
12. Tosato G, Taga K, Angiolillo A, and Sgadari C. Epstein-Barr virus as an agent of haematological disease. Bailiere's Clin Haematol 1995; 8: 165-99.
13. Baumforth KRN, Young LS, Flavell KJ et al. The Epstein-Barr virus and its association with human cancers. Mol Pathol 1999; 52: 307-22.
14. Anagnostopoulos I, and Hummel M. Epstein-Barr virus in tumours. Histopathology 1996; 29: 297-315.
15. Ambinder RF. Epstein-Barr virus associated lymphoproliferations in the AIDS setting. Eur J Cancer 2001; 37: 1209-16.
16. Kawa K. Epstein-Barr-Virus-Associated Diseases in Humans. Int J Hematol 2000; 71: 108-17.
17. Chai SP, Peh SC, Lim MY, and Gudum HR. The Pattern of Lymphoma in East Malaysian Patients as Experienced in the University Hospital, Kuala Lumpur. Malay J Pathol 1999; 21: 45-50.
18. Peh SC, and Poppema S. Consensus Report - Histopathological reporting of malignant lymphoma. Malay J Pathol 1999; 21: 63-7.
19. Population and Housing Census of Malaysia 1991: State Population Report Sabah. Department of Statistic Malaysia 1995.
20. Seow A, Lee J, Sng I et al. Non-Hodgkin's lymphoma in an Asian population. Cancer 1996; 77: 1899-904.
21. Mancer K. The Spectrum of Lymphoma in Malaysia: A Histopathological Study Utilizing Immunophenotyping. Malay J Pathol 1990; 12: 77-88.
22. Ho FCS, Todd D, Loke SL et al. Clinico-pathological features of malignant lymphomas in 294 Hong Kong Chinese patients. Retrospective study covering an eight-year period. Int J Cancer 1984; 34: 143-8.
23. Peh SC, Gudum HR, Tai YC et al. Spectrum of Malignant Lymphoma in Sarawak General Hospital. J Clin Exp Hematopath 2001; 41: 45-9.
24. Pearce N, and Bethwaite P. Increasing incidence of Non-Hodgkin's lymphoma: Occupational and Environmental Factors. Cancer Res (Suppl) 1992; 52: 5495s-500s.
25. Zahm H, and Blair A. Pesticides and Non-Hodgkin's lymphoma. Cancer Res (Suppl) 1992; 52: 5485s-8s.
26. Scherr PA, Hutchison GB, and Neiman RS. Non-Hodgkin's lymphoma and Occupational Exposure. Cancer Res (Suppl) 1992; 52: 5503s-9s.
27. Blair A, Linos A, Stewart PA et al. Comments on occupational and environmental factors in the origin of non-Hodgkin's lymphoma. Cancer Res (Suppl) 1992; 52: 5501s-2s.
28. Anderson JR, Armitage JO, and Weisenburg DD. Epidemiology of the non-Hodgkin's lymphomas: Distribution of the major subtypes differ by geographic locations. Ann Oncol 1998; 9: 717-20.
29. Harrington DS, Ye YL, Weisenburger DD et al. Malignant lymphoma in Nebraska and Guangzhou, China. Hum Pathol 1987; 18: 924-8.
30. Peh SC, Kim LH, Thanaletchimy N et al. Spectrum of malignant lymphomas in Klang Hospital. Malay J Pathol 2000; 22: 13-20.
31. Garg A, Dawar R, Agarwal V et al. Non-Hodgkin's Lymphoma in Northern India. A retrospective analysis of 238 cases. Cancer 1985; 56: 972-7.
32. Intragumtornchai T, Wannakrairoj P, Chaimongkol B et al. Non-Hodgkin's lymphomas in Thailand. Cancer 1996; 78: 1813-9.
33. Peh SC. Host Ethnicity Influences non-Hodgkin's Lymphoma (NHL) Subtype Frequency and Epstein-Barr Virus Association Rate: The Experience of a Multiethnic Patient Population in Malaysia. Histopathology 2001; 38: 458-65.
34. Elenitobo-Johnson KSJ, Gascoyne RD, Lim MS et al. Homozygous Deletions at Chromosome 9p21 Involving p16 and p15 are Associated with Histologic Progression in Follicle Center Lymphoma. Blood 1998; 91: 4677-85.
35. Dalla-Favera R, Ye BH, Lo Coco F et al. Identification of genetic lesions associated with diffuse large-cell lymphoma. Ann Oncol 1994; 5 (Suppl 1): S55-S60.
36. Zelenetz AD, Chen TT, and Levy R. Histologic Transformation of Follicular Lymphoma to Diffuse Lymphoma Represents Tumor Progression by a Single Malignant B Cell. J Exp Med 1991; 173: 197-207.
37. Hi J, Kan S, Pereira M, Parmar SS et al. Bancroftian Filariasis and Malaria in island and hinterland populations in Sabah, Malaysia. Trop Geogr Med 1985; 37: 93-101.
38. Lim ES. Current status of malaria in Malaysia. Southeast Asian J Trop Med Public Health 1992; 23: 43-9.
39. Hinuma Y, Komoda H, Chosa T et al. Antibodies to adult T-cell leukaemia virus associated antigen (ATLA) in sera from patients with ATL and controls in Japan: A nationwide sero-epidemiological study. Int J Cancer 1982; 29: 631-5.
40. Lee SS, Cho KJ, Kim CW, and Kang YK. Clinicopathological analysis of 501 non-Hodgkin's lymphomas in Korea according to the Revised European-American Classification of Lymphoid Neoplasms. Histopathology 1999; 35: 345-54.
41. Queen Elizabeth Hospital Patient's Admission and Census Data for the year 1997, 1998 and 1999 from the Ministry of Health Information Data System.